Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease
Varman T. Samuel(VA Connecticut Research and Education Foundation), Gerald I. Shulman(Howard Hughes Medical Institute), Zhenxiang Liu(Yale University), Brett P. Monia(Ionis Pharmaceuticals (United States)), John G. Geisler(Ionis Pharmaceuticals (United States)), Sara A. Beddow(Yale University), Xianman Zhang(Yale University), Mario Kahn(Yale University), Amy Wang(Yale University), Sanjay Bhanot(Ionis Pharmaceuticals (United States))
Cited by 480
Related Papers
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity
|Journal of Clinical Investigation|1999|1.3k